ZYDUSLIFENSEZydus Lifesciences LimitedMediumNeutral
Announced Wed, 13 May · 10:14 IST

Zydus Lifesciences Limited has informed the Exchange regarding Cessation of Mr Apurva S. Diwanji as Non- Executive Independent Director of the company w.e.f. May 12, 2026.

Management Changes View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.0%1-day move
₹928.60
prior close
₹936.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+0.6+0.6+0.2+7.0+8.5+6.8+9.6+12.0+11.8+16.7+17.1+21.8
Up moveDown movePending
AI summary

Zydus Lifesciences has announced that Mr. Apurva S. Diwanji has ceased to be a Director (including as Independent Director) of the company effective May 12, 2026. The cessation was due to the completion of his tenure, which is a normal and expected event in corporate governance. The company has expressed sincere appreciation for his valuable contributions, dedication, integrity, and professional expertise during his tenure. The disclosure was made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

Likely market impact

This is a routine board change following tenure completion and does not indicate any governance concerns or operational issues. Shareholders need not be alarmed as independent directors typically serve fixed terms.